CSP is a global specialty pharmaceutical company focused on the development and commercialisation of innovative rare, ophthalmology and speciality diseases to address high unmet medical needs and improve the lives of patients in the greater China marketplace.
Partnering and scientific collaborations are key elements of CSP strategy as we continue to expand our portfolio of innovative products.
For more information, please contact our VP of Business development: simon.bennett@cspharmaceuticals.com